Annual Statements Open main menu

Valiant Eagle, Inc. - Quarter Report: 2011 September (Form 10-Q)

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C., 20549

 

Form 10-Q 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2011

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to  ___________

Commission File Number: 333-1418158

 

PURESPECTRUM, INC.
(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

41-2233202

(State or Other Jurisdiction of
Incorporation or Organization)

(I.R.S. Employer
Identification No.)

161 Bay Street, 27th Floor
Toronto, Ontario M5J2S1

(Address of principal executive offices, including zip code)

 

7 Dey Street
Suite 1503
New York, NY 10007
(Former address of principle executive offices, including zip code)

 

Registrant’s telephone number, including area code; (416) 792-5555

 

Indicate by check mark whether the Registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.       Yes         No o

 

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate website, if any, every interactive data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes o       No o

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

(Check one):

Large accelerated filer o

Accelerated filer o

Non-accelerated filer o

Smaller reporting company

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).             YES ☐    NO

 

As of September 30, 2011 there were 876,368,278 shares of our $0,0001 par value common stock issued and outstanding.

 

 
 

 

Available Information

 

Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all amendments to those reports that we file with the Securities and Exchange Commission, or SEC, are available at the SEC’s public reference room at 100 F Street, N.E., Washington, D.C. 20549. The public may obtain information on the operation of the public reference room by calling the SEC at 1-800-SEC-0330. The SEC also maintains a website at www.sec.gov that contains reports, proxy, and information statements and other information regarding reporting companies.

 

TABLE OF CONTENTS 

 

 

 

 

 

Page

 

PART I

 

ITEM 1.

Condensed Financial Statements (unaudited)

 

 

Balance Sheets as of September 30, 2011 and December 31, 2010

1

 

Statements of Operations for the Nine Months Ended September 30, 2011 and 2010

2

 

Statements of Cash Flows for the Nine Months Ended September 30, 2011 and 2010

3

 

Statements of Changes in Stockholders’ Deficit for the Period From December 31, 2010 through September 30, 2011

4

 

Notes to Condensed Financial Statements

5-7

 

 

 

ITEM 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

8-9

ITEM 3.

Quantitative and Qualitative Disclosures About Market Risk (Not Applicable)

10

ITEM 4T.

Controls and Procedures

10

 

 

 

 

PART II

 

ITEM 1.

Legal Proceedings

11

ITEM 1A.

Risk Factors (Not Applicable)

11

ITEM 2.

Unregistered Sales of Equity Securities and Use of Proceeds

11

ITEM 3.

Defaults Upon Senior Securities

11

ITEM 4.

[Removed and Reserved]

 

 

 

 

ITEM 5.

Other Information

11

ITEM 6.

Exhibits

11

 

SIGNATURES

12

 

 

 

 

PART I

 

Item 1. Condensed Financial Statements

 

PureSpectrum, Inc.

Condensed Balance Sheets

 

 

 

September 30,

 

 

December 31,

 

 

 

2011

 

 

2010

 

 

 

(Unaudited)

 

 

(Unaudited)

 

Assets

 

 

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

 

 

Cash

 

$

200

 

 

$

31,294

 

Accounts Receivables

 

 

399

 

 

 

1,659

 

Inventory

 

 

31,669

 

 

 

69,568

 

Other Current Assets

 

 

11,818

 

 

 

12,145

 

Total Current Assets

 

 

44,086

 

 

 

114,666

 

 

 

 

 

 

 

 

 

 

Furniture & Equipment, net of accumulated depreciation

 

 

154,073

 

 

 

187,910

 

 

 

 

 

 

 

 

 

 

Other Assets

 

 

 

 

 

 

 

 

Patents, net of accumulated amortization

 

 

584,207

 

 

 

586,613

 

Trademarks

 

 

164,110

 

 

 

164,110

 

Total Assets

 

$

946,476

 

 

$

1,053,299

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Deficit

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Checks Drawn In Excess of Bank Balance

 

 

 

 

 

 

Accounts Payable

 

 

1,335,877

 

 

 

1,263,065

 

Accrued Expenses

 

 

602,071

 

 

 

290,690

 

Payroll Liabilities

 

 

243,853

 

 

 

243,853

 

Convertible Debt, current portion, net of discount $5,578 and $218,460, respectively

 

 

829,627

 

 

 

591,540

 

Notes Payable, current poriton

 

 

224,305

 

 

 

224,305

 

Notes Payable-Related parties, current poriton

 

 

61,650

 

 

 

61,650

 

Total Current Liabilities

 

 

3,297,383

 

 

 

2,675,103

 

 

 

 

 

 

 

 

 

 

Long-term Liabilities

 

 

 

 

 

 

 

 

Accounts Payable, satisfied by common stock issuance

 

 

 

 

 

 

Accrued expenses, satisfied by common stock issuance

 

 

 

 

 

 

Notes Payable-Related parties, satisfied by common stock issuance

 

 

 

 

 

 

Convertible Debentures, net of discount $419,250 and $670,800, respectively

 

 

698,750

 

 

 

447,200

 

Total Long-term Liabilities

 

 

698,750

 

 

 

447,200

 

 

 

 

 

 

 

 

 

 

Stockholders’ Deficit

 

 

 

 

 

 

 

 

Preferred Stock, $0.0001 Par Value, 50,000,000 Shares Authorized, 2,000,000 and 2,000,000 Shares Issued and Outstanding at September 30, 2011 and December  31, 2010, respectively

 

 

200

 

 

 

200

 

Common Stock, $0.0001 Par Value, 900,000,000 Shares Authorized, 876,368,278 and 422,651,503 Shares Issued at September 30, 2011 and December 31, 2010, respectively

 

 

87,637

 

 

 

43,416

 

Additional Paid In Capital

 

 

20,240,984

 

 

 

20,241,473

 

Treasury Stock

 

 

 

 

 

(170,000

)

Prepaid Loan Costs

 

 

 

 

 

 

Accumulated Deficit

 

 

(23,378,478

)

 

 

(22,184,093

)

Total Stockholders’ Deficit

 

 

(3,049,657

)

 

 

(2,069,004

)

Total Liabilities and Stockholders’ Deficit

 

$

946,476

 

 

$

1,053,299

 

 

The accompanying notes are an integral part of the condensed financial statements.

 

1

 

 

PureSpectrum, Inc.

Condensed Statements of Operations (Unaudited)

 

 

 

For the three months ended September 30,

 

 

For the nine months ended September 30,

 

 

 

2011

 

 

2010

 

 

2011

 

 

2010

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

 

 

$

11,603

 

 

$

26,108

 

 

$

30,353

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of Goods Sold

 

 

 

 

 

10,091

 

 

 

36,261

 

 

 

33,422

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit on Sales

 

$

 

 

$

1,512

 

 

$

(10,153

)

 

$

(3,069

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Share Based Compensation

 

 

 

 

 

26,771

 

 

 

 

 

 

635,313

 

Research and Development

 

 

 

 

 

24,226

 

 

 

 

 

 

273,316

 

Other General and Administrative Expenses

 

 

52,499

 

 

 

466,231

 

 

 

238,537

 

 

 

2,806,374

 

Total Expense

 

 

52,499

 

 

 

517,228

 

 

 

238,537

 

 

 

3,715,003

 

Net Loss from Operations

 

 

(52,499

)

 

 

(515,716

)

 

 

(248,690

)

 

 

(3,718,072

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other (Expense) Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Income

 

 

 

 

 

 

 

 

 

 

 

 

Gain on AP Settlement

 

 

 

 

 

 

 

 

 

 

 

31,987

 

Loss on Asset Disposal

 

 

 

 

 

 

 

 

 

 

 

 

Inventory Impairment Write Down

 

 

 

 

 

(1,286,529

)

 

 

 

 

 

(1,286,529

)

Interest Expense

 

 

(249,359

)

 

 

(871,498

)

 

 

(945,694

)

 

 

(2,810,242

)

Total Other (Expense) Income

 

 

(249,359

)

 

 

(2,158,027

)

 

 

(945,694

)

 

 

(4,064,784

)

Net Loss

 

$

(301,858

)

 

$

(2,673,743

)

 

$

(1,194,384

)

 

$

(7,782,856

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Basic & Fully Diluted Outstanding Shares

 

 

675,237,213

 

 

 

389,150,842

 

 

 

538,870,309

 

 

 

172,251,094

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic & Fully Diluted Loss per Share

 

$

(0.00

)

 

$

(0.01

)

 

$

(0.00

)

 

$

(0.05

)

 

The accompanying notes are an integral part of the condensed financial statements.

 

2

 

 

 

PureSpectrum, Inc.

Condensed Statements of Cash Flow (Unaudited)

 

   For the nine months ended September 30, 
   2011   2010 
Operating activities          
Net loss  $(1,194,384)  $(7,782,856)
Adjustments to reconcile net loss to net cash used by operating activities:          
Depreciation and amortization   12,831    38,295 
Share based compensation       635,311 
Amortization of detachable warrants issued with convertible debt       458,710 
Amortization of the beneficial conversion feature   562,432    2,114,566 
Services exchanged for common stock       135,000 
Stock issued for commitment fee collateral       250,000 
Amortization of prepaid loan costs       106,805 
Gain on Settlement of Accounts Payable        
Loss on disposal od assets        
(Increase) decrease in:          
Accounts receivables   1,260    2,111 
Inventory   207,939    1,465,091 
Other current assets   327    25,249 
Increase (decrease) in:          
Accounts payable   (97,228)   277,197 
Accrued expenses   373,319    138,720 
Payroll liabilities       180,013 
Total adjustments   1,060,878    5,827,068 
Net cash used by operating activities   (133,506)   (1,955,788)
           
Investing Activities          
Purchase of furniture and equipment   23,412    (9,698)
Development of Patents and trademarks         
Purchase of Treasury Stock        
Net cash used by investing activities   23,412    (9,698)
           
Cash Flows from Financing Activities          
Increase in Checks Drawn in Excess of Bank Balance       (4,706)
Proceeds from borrowing   79,000    867,305 
Proceeds from issuance of stock issued for conversion of debt        
Repayment of borrowing       (5,000)
Proceeds from issuance of common stock       479,593 
Proceeds from exersice of options and warrants       630,100 
Proceeds from debt converted to common stock        
Net cash provided by financing activities   79,000    1,967,292 
           
Net (Decrease) Increase in Cash   (31,094)   1,805 
           
Cash at Beginning of Period   31,294    609 
           
Cash at End of Period  $200   $2,414 
           
Supplemental disclosures of cash flow information and noncash investing and financing activities:          
Debt and accrued interest converted to common stock  $149,237   $889,831 
Satisfaction of accounts payable through issuance of common stock  $   $817,501 
Cancellation of PSPM shares not exchanged for PSRU shares  $   $7 
Detachable warrants issued with convertible debt  $   $352,063 
Benefical conversion feature of convertible debt  $64,500   $1,899,429 
Property and equipment additions included in accounts payable  $   $8,517 
Inventory additions included in accounts payable  $170,040   $483,684 
Intangible asset additions included in accounts payable  $   $62,677 

 

The accompanying notes are an integral part of the condensed financial statements.

 

3 

 

 

PureSpectrum, Inc.

Statements of Changes in Stockholders’ Deficit

For the Period From December 31, 2009 through September 30, 2011

 

   Preferred
Shares
   Preferred
Amount
   Common
Shares
   Common
Amount
   Additional Paid
in Capital
   Prepaid Loan
Costs
   Accumulated
Deficit
   Treasury Stock   Total
Stockholders’
Deficit
 
Balance - December 31, 2009      $    215,455,090   $21,546   $13,875,015   $(106,805)  $(14,211,159)  $   $(421,403)
                                              
Stock Issued for Cash (Unaudited)           12,571,312    1,257    328,336                 329,593 
Stock Issued for Services (Unaudited)   2,000,000    200    2,616,667    262    134,738                135,200 
Share Based Compensation (Unaudited)           45,000,000    4,500    635,312                639,812 
Issuance of warrants and BCF associated with convertible debt (Unaudited)                   2,341,491                2,341,491 
Stock issued upon exercise of warrants and options (Unaudited)           25,694,662    2,570    627,530                630,100 
Stock issued upon debt conversion (Unaudited)           122,648,521    12,265    1,845,066                 1,857,331 
Stock issued upon redemption of convertible debentures (Unaudited)           233,333    23    34,977                35,000 
Stock issued for commitment fee collateral (Unaudited)           10,000,000    1,000    249,000                250,000 
Amortization of Prepaid Loan Costs (Unaudited)                       106,805            106,805 
Cancellation of expired stock (Unaudited)           (68,743)   (7)   7                 
Purchase of treasury stock (Unaudited)                               (170,000)   (170,000)
Net Loss (Unaudited)                           (7,972,934)       (7,972,934)
Balance - December 31, 2010 (Unaudited)   2,000,000   $200    434,150,842   $43,416   $20,071,473   $   $(22,184,093)  $(170,000)  $(2,239,005)
                                              
Stock Issued for Cash (Unaudited)                                     
Stock Issued for Services (Unaudited)                                    
Share Based Compensation (Unaudited)                                    
Issuance of warrants and BCF associated with convertible debt (Unaudited)                   64,500                64,500 
Stock issued upon exercise of warrants and options (Unaudited)                                    
Stock issued upon debt conversion (Unaudited)           456,837,500    45,684    273,551                 319,235 
Stock issued upon redemption of convertible debentures (Unaudited)                                    
Stock issued for commitment fee collateral (Unaudited)                                    
Amortization of Prepaid Loan Costs (Unaudited)                                    
Cancellation of treasury stock (Unaudited)           (14,620,064)   (1,462)   (168,538)           170,000     
Purchase of treasury stock (Unaudited)                                    
Net Loss (Unaudited)                           (1,194,384)       (1,194,384)
Balance - September 30, 2011 (Unaudited)   2,000,000   $200    876,368,278   $87,638   $20,240,985   $   $(23,378,478)  $   $(3,049,655)

 

The accompanying notes are an integral part of the financial statements.

 

4 

 

NOTES TO CONDENSED FINANCIAL STATEMENTS (unaudited)

 

NOTE 1 - BASIS OF PRESENTATION

 

The accompanying unaudited financial statements were prepared in accordance with instructions for Form 10-Q and, therefore, do not include information or footnotes necessary for a complete presentation of financial condition, results of operations, and cash flows in conformity with U.S. Generally Accepted Accounting Principles US GAAP. All adjustments, consisting of normal recurring accruals, which, in the opinion of management, are necessary for fair  presentation of the financial statements, have been included. The results of operations for the period ended September 30, 2011, are not necessarily indicative of the results which may be expected for the entire fiscal year or for any other period. For further information, refer to the financial statements and footnotes thereto for the year ended December 31, 2010 included in PureSpectrum Inc.’s Form 10-K.

 

Certain prior year amounts have been reclassified to conform to the 2011 presentation. 

 

NOTE 2 – RECENT ACCOUNTING PRONOUNCEMENTS

 

The Company’s management does not believe that recent codified pronouncements by the Financial Accounting Standards Board FASB will have a material impact on the Company’s current or future financial statements.

 

NOTE 3 - SUMMARY OF ORGANIZATION

 

PureSpectrum, Inc. (the “Company”), formerly International Medical Staffing, Inc., is a Delaware corporation incorporated on March 21, 2007. The Company is in the business of developing, marketing, licensing, and contract manufacturing of lighting technology for use in residential, commercial, and industrial applications worldwide.

 

The Company is authorized to issue 950 million shares, consisting of (a) 900 million shares of common stock, par value $0.0001 per share and (b) 50 million shares of preferred stock, par value $0.0001 per share, which may be issuable in one or more series. Each common share is entitled to one vote and shareholders have no preemptive or conversion  rights. As of September 30, 2011, and December 31, 2010, there were 876,368,278 and 351,691,363 common shares issued and outstanding, respectively. The Company’s Board of Directors may, without further action by the shareholders, direct the issuance of preferred stock for any proper corporate purpose with preferences, voting powers, conversion rights, qualifications, special or relative rights and privileges which could adversely affect the voting power or other rights of shareholders of common stock. As of September 30, 2011, and December 31, 2010, there were 2,000,000 and 2,000,000 shares of the Company’s preferred stock issued or outstanding, respectively. Each Series B preferred share entitles the holder thereof to five hundred (500) votes per share and may vote on any action requiring any class of shares to vote.

 

NOTE 4 – GOING CONCERN

 

The accompanying financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company as a going concern and the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses from operations of $1,194,384 for the Nine Months ended September 30, 2011. In addition, at September 30, 2011, the Company has an accumulated deficit of $23,378,478 and negative working capital of $3,253,297.

 

These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.

 

The Company recorded its first revenues in October 2009 and is no longer a development stage company. The Company has not yet generated sufficient working capital to support its operations. The Company’s ability to continue as a going concern is dependent, among other things, on its ability to minimize costs, enter into revenue generating contracts and obtain additional revenues to eventually attain a profitable level of operations.

 

The Company has been engaged in developing, marketing, licensing, and contract manufacturing of fluorescent lighting technology for use in residential, commercial, and industrial applications worldwide. There can be no assurance that the Company will be successful in the commercialization of the fluorescent lighting technology that will generate sufficient revenues to sustain the operations of the Company.

 

5

Management plans to obtain additional capital investments to enable the Company to continue operations and increase revenues in 2011. There is no assurance that management will be able to successfully generate revenue and/or reduce expenses sufficient to attain profitability, or continue to attract the capital necessary to support the business.

 

NOTE 5 - NET LOSS PER SHARE

 

Basic net loss per share is computed by dividing net loss attributable to commons shareholders by the weighted average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted net loss per share reflects the potential dilution that could occur if securities were exercised or converted into common stock using the treasury stock method. Diluted net loss per share is computed by dividing the net loss by the weighted average number of common share equivalents outstanding for the period determined using the treasury-stock method. For  purposes of this calculation, convertible preferred stock, stock options and warrants are considered to be common stock equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive.

 

NOTE 6 – NOTES PAYABLE 

Notes payable consist of the following:

 

 

 

 September 30, 2011

 

 

 December 31, 2010

 

Note payable, unsecured, to shareholder at 5% interest, payable upon demand

 

 

61,650

 

 

 

61,650

 

Note payable, unsecured, to officer at 5% interest, payable upon demand

 

 

 

 

 

 

 

 

 

61,650

 

 

 

61,650

 

Less current portion

 

 

61,650

 

 

 

61,650

 

Long term portion

 

 

 

 

 

 


NOTE 7 – CONVERTIBLE NOTES AND DEBENTURES PAYABLE 

Convertible debt consists of the following:

 

 

 

September 30, 2011

 

 

December 31, 2010

 

Convertible notes issued to an investor, net of discount of $5,347 and $21,246 as of September 30, 2011 and December 31, 2010 respectively.

 

 

257,641

 

 

 

213,754

 

 

 

 

 

 

 

 

 

 

Convertible debentures issued to an investor, net of discount of $419,250 and $670,800 as of September 30, 2011 and December 31, 2010 respectively.

 

 

698,750

 

 

 

447,200

 

 

 

 

 

 

 

 

 

 

Convertible notes issued to an investor, net of discount of $0 and $0 as of September 30, 2011 December 31, 2010 respectively.

 

 

174,452

 

 

 

162,582

 

 

 

 

 

 

 

 

 

 

Convertible notes issued to an investor, net of discount of $0 and $0 as of September 30, 2011 December 31, 2010 respectively.

 

 

125,000

 

 

 

125,000

 

 

 

 

 

 

 

 

 

 

Convertible notes issued to an investor, net of discount of $0 and $0 as of September 30, 2011 December 31, 2010 respectively.

 

 

178,265

 

 

 

15,204

 

 

 

 

 

 

 

 

 

 

Convertible notes issued to an investor, net of discount of $0 and $0 as of September 30, 2011 December 31, 2010 respectively.

 

 

75,000

 

 

 

75,000

 

 

 

 

 

 

 

 

 

 

Convertible notes issued to an investor, net of discount of $231 and $0 as of September 30, 2011 and December 31, 2010 respectively.

 

 

19,269

 

 

 

 

 

 

 

1,528,377

 

 

 

1,038,740

 

Less current portion

 

 

698,750

 

   

591,540

 

Long term portion 

   

829,627

     

447,200

 

 

6

 

NOTE 8 – OPTIONS AND WARRANTS

 

Options and warrants generally vest immediately upon grant. The Company has historically issued warrants related to raising capital. As of September 30, 2011, the Company has 44,136,929 options outstanding and exercisable and  72,000,000 warrants outstanding and exercisable.

 

Information about stock options and warrants outstanding at September 30, 2011 and December 31, 2010 is summarized below: 

 

 

 

Shares

 

 

Weighed Average Exercise
Price Per Share

 

 

Weighed Average Remaining
Contractual Life

 

 

 

 

Warrants

 

 

 

Stock
Options

 

 

 

Warrants

 

 

 

Stock
Options

 

 

 

Warrants

 

 

 

Stock
Options

 

Outstanding at December 31, 2010

 

 

72,000,000

 

 

 

44,136,929

 

 

 

0.750

 

 

 

0.060

 

 

 

3.2

 

 

 

3.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled or Expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2011

 

 

72,000,000

 

 

 

44,136,929

 

 

 

0.750

 

 

 

0.060

 

 

 

2.7

 

 

 

2.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at September 30, 2011

 

 

72,000,000

 

 

 

44,136,929

 

 

 

0.750

 

 

 

0.060

 

 

 

2.7

 

 

 

2.8

 

 


NOTE 9 - OPERATING LEASES AND OTHER COMMITMENTS AND CONTINGENCIES

 

Rental of office space and data processing equipment under operating leases were approximately $6,000 and $78,752 for the Nine Months ended September 30, 2011 and 2010, respectively.

 

NOTE 10 - RELATED PARTY TRANSACTIONS

 

Not applicable

 

NOTE 11 - SUBSEQUENT EVENTS

 

On December 5, 2011, Barclay Lyons transferred the Series B preferred shares to OTC Ventures, Inc., an entity controlled by Cedric Atkinson, our new chief executive officer. As a result of the foregoing, Mr. Atkinson will now be able to elect the Company’s Board of Directors and approve any action requiring the vote of the holders of the Company’s common stock.

 

On December 5, 2011 Gregory Clements tendered his resignation as an officer and director of the Company. There was no disagreement between the Company and Mr. Clements regarding the Company’s operations or financial reporting.

 

Concurrently with his resignation, Mr. Clements appointed Cedric Atkinson to serve as the Company’s sole officer and director.

 

7

 

ITEM 2. - Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Certain statements in this quarterly report on Form 10-Q contain or may contain forward-looking statements that are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Generally, the words “believes”, “anticipates,” “may,” “will,” “should,” “expect,” “intend,” “estimate,” “continue,” and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements which include, but are not limited to, statements concerning the Company’s expectations regarding its working capital requirements, financing requirements, business prospects, and other statements of expectations, beliefs, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. These forward-looking statements were based on various factors and were derived utilizing numerous assumptions and other factors that could cause our actual results to differ materially from those in the forward-looking statements. These factors include, but are not limited to, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors. Most of these factors are difficult to predict accurately and are generally beyond our control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. Readers should carefully review this quarterly report in its entirety, including but not limited to our financial statements and the notes thereto. Except for our ongoing obligations to disclose material information under the Federal securities laws, we undertake no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events. For any forward-looking statements contained in any document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.

 

THE FOLLOWING DISCUSSION OF THE RESULTS OF OUR OPERATIONS AND FINANCIAL CONDITION SHOULD BE READ IN CONJUNCTION WITH OUR FINANCIAL STATEMENTS AND THE NOTES THERETO INCLUDED ELSEWHERE IN THIS REPORT.

 

Background

 

The Company is engaged in developing, marketing, licensing and contract manufacturing of fluorescent lighting technology for use in residential, commercial and industrial applications.

 

The quest for increased energy efficiency in commercial and industrial lighting applications is growing and demand for dimmable linear fluorescent lighting is expected to expand during the coming years. Our goal is to expand the product line, marketing efforts and sales of multiple lines of dimmable linear fluorescent products. Our objective is to offer a diverse commercial/industrial product line and take advantage of demonstrated needs in the marketplace. The Company believes interest in its dimmable CFLs will increase when the Company is capable of offering a full line of bulbs to include multiple styles and wattages which address varying consumer demands. Due to financial constraints, we have not been able to pursue these market opportunities and there can be no assurance that we will be able to implement our business strategy at any time in the future.

 

Our lack of working capital has adversely affected product development and manufacturing of both proprietary and non-proprietary Compact Fluorescent Lamps (CFL).

 

Our products were initially sold through distributors. We were not successful and changed our business plan to focus on Internet sales and other direct marketing methods. In order to finance its ongoing operations, the Company executed multiple secured convertible promissory notes with several creditors. The secured creditors filed U.C.C.   security interests encumbering all of the Company’s assets now owned or hereafter acquired and the proceeds thereof.   The secured convertible promissory notes are in default.

 

 

 

8

 

The Company will continue to look into various financing opportunities. However, there is no assurance that additional financing will be available to us when needed or if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain additional financing on a timely basis, we will not be able to meet our obligations as they become due and we will be forced to decrease or cease operations. The issuance of additional equity securities by us could result in significant dilution in the equity interests of our current stockholders. Obtaining additional loans, including commercial loans, assuming those loans would be available, will increase our liabilities and future cash commitments

 

Results of Operations: For the Nine Months ended September 30, 2011 and 2010

 

Revenues

 

For the Nine Months ended September 30, 2011, we recognized $26,108 in revenues compared to $30,353 in revenues for the Nine Months ended September 30, 2010.

 

Expenses

 

For the Nine Months ended September 30, 2011, our expenses were $238,537 compared with $3,718,072 for the Nine Months ended September 30, 2010. These expenses were primarily comprised of professional and consulting fees ($45,000 for 2011 compared to $906,081 for 2010), compensation ($110,242 for 2011 compared to $689,931 for 2010), other general and administrative expenses ($86,295 for 2011 compared to $1,237,895 for 2010).

 

Net Income (loss)

 

For the Nine Months ended September 30, 2011, our net loss was $1,194,384 compared with a net loss of $7,782,856 for the Nine Months ended September 30, 2010.

 

Liquidity and Capital Resources

 

As of September 30, 2011, we had a working capital deficit of $3,253,297. This compares to a working capital deficit of $2,560,437 as of December 31, 2010. Cash on hand was $200 compared to cash of $31,294 as of December 31, 2010. Inventories were $31,669 and $69,568 as of September 30, 2011 and December 31, 2010, respectively. Accounts payable as of September 30, 2011 were $1,335,877 compared to $1,263,065 as of December 31, 2010. Current portion of convertible notes payable as of September 30, 2011 were $829,627 and compares to $591,540 as of December 31, 2010.

 

Going Concern

 

Our financial statements contain a note regarding concern about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of that uncertainty.

 

Off Balance Sheet Arrangements

 

None

 

Critical Accounting Policies

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date the financial statements and the reported amounts of revenue and expenses during the period. Accordingly, actual results could differ from those estimates. Note 1 of the “Notes to Financial Statements” in our annual report on Form 10-K for the year ended December 31, 2010, includes a summary of the significant accounting policies and methods used in the preparation of our financial statements. For the period ended September 30, 2011, there were no significant changes to our critical accounting policies.

 

9

 

ITEM 3. - Quantitative And Qualitative Disclosures About Market Risk

 

Not applicable.

 

ITEM 4. - Controls and Procedures.

 

(a)

Disclosure Controls and Procedures.

 

Management’s Report on Internal Control over Financial Reporting.

 

The Company’s management conducted an evaluation of the effectiveness of its internal control over financial reporting as of September 30, 2011 using the criteria set forth in the Internal Control over Financial Reporting - Guidance for Smaller Public Companies issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based upon the evaluation, Management concluded that the Company’s internal control over financial reporting was  not effective as of September 30, 2011, because of material weaknesses in its internal control over financial reporting.

 

A material weakness is a control deficiency that results in a more than remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely  basis by employees in the normal course of their assigned functions. Management concluded that we have several material weaknesses in our internal control over financial reporting because of inadequate segregation of duties over authorization, review and recording of transactions as well as the financial reporting of such transactions. Due to the Company’s limited resources, management has not developed a plan to mitigate the above material weaknesses without the assistance of an independent escrow agent. In furtherance thereof, and with the agreement of the secured creditors, all monies received from either product sales or from any financing, are deposited in an attorney’s escrow account established by the  Company at the request of the secured creditors. Distributions from the escrow account must be approved by the secured creditors

 

Despite the existence of these material weaknesses, we believe the financial information presented herein is materially correct and in accordance with the generally accepted accounting principles.

 

 

(b)

Changes in Internal Control over Financial Reporting.

 

Except as set forth above, there have been no changes in the Company’s processes and procedures during the Nine Months ended September 30, 2011, that materially affected or is reasonably expected to materially affect the Company’s internal control over financial reporting.

 

(c)

Inherent Limitations of Disclosure Controls and Internal Controls over Financial Reporting

 

Because of its inherent limitations, internal controls over financial reporting may not prevent or detect misstatements. Projections of any evaluation or effectiveness to future periods are subject to risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

10

 

PART II

 

ITEM 1. - Legal Proceedings

 

There has been no change in status in connection with the pending litigation with Arcata Electronics, Inc. since reported in our prior quarterly report. ( Superior Court of Los Angeles Case No. YCO64215. )

 

ITEM 1A. Risk Factors

 

There have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10- K for the period ended December 31, 2010.

 

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

During the Nine Months ended September 30, 2011 the company issued 456,837,500 common shares to satisfy outstanding debt obligations

 

At all times relevant:

 

-  the sale was made to a sophisticated or accredited investor;

 

-  we gave the purchaser the opportunity to ask questions and receive answers concerning the terms and conditions of the offering and to obtain any additional information which we possessed or could acquire without unreasonable effort or expense that is necessary to verify the accuracy of information furnished;

 

-  at a reasonable time prior to the sale of securities, we advised the purchaser of the limitations on resale of the securities; and

 

-  neither we nor any person acting on our behalf sold the securities by any form of general solicitation or general advertising

 

In issuing the foregoing securities, we relied on the exemptive provisions of Section 4(2) or Regulation D of the  Securities Act.

 

ITEM 3. Defaults Upon Senior Securities

 

On October 29, 2010, the Company entered a Forbearance Agreement (the “Agreement”) with its secured creditors. In order to finance its ongoing operations, the Company executed multiple secured convertible promissory notes totaling $756,436 with several creditors.

 

These notes are in default.

 

The secured creditors have filed U.C.C. security interests encumbering all of the Company’s assets now owned or hereafter acquired and the proceeds thereof. Barclay Lyons, LLC has a priority security interest.

 

ITEM 4 - [Removed and Reserved]

 

ITEM 5. - Other Information

 

There is no information that was required to be disclosed by the Company on Form 8-K during the third quarter of 2011, that was not reported.

 

ITEM 6 - Exhibits 

 

Exhibit No.   Description
31.1*   Certifications of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certifications of Principal Financial and Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*   Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Principal Financial and Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS ++   XBRL Instance Document
101.SCH ++   XBRL Taxonomy Extension Schema Document
101.CAL ++   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF ++   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB ++   XBRL Taxonomy Extension Label Linkbase Document
101.PRE ++   XBRL Taxonomy Extension Presentation Linkbase Document

 

* Filed herewith

 

++XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a report for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections. 

 

 

11

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

PURESPECTRUM, INC.

 

By:

/s/Cedric Atkinson

 

 

 

Cedric Atkinson

 

President/CEO and CFO

 

(Principal Executive Officer)

 

DATE: 01/19/2012 

12